The kit measures accumulation of a protein that is a marker for the disease a rare advance in tackling a condition that affects millions worldwide.Japan's Sysmex Corp says it has received regulatory approval in Japan for a blood test to detect amyloid beta in the brain, a characteristic of Alzheimer's disease.
[
add
]
[
|
|
...
]